People
Bedell Cristin has appointed Valerie Georges-Thomas to head up the firm’s British Virgin Islands office.
Georges-Thomas (pictured) was previously a partner at Appleby in the firm’s corporate and commercial practice group. Her appointment follows on from Bedell opening an office in Singapore in July, headed by BVI lawyer Stephen Adams.
Bedell’s BVI law practice, represented in Jersey, Singapore and the BVI, acts as a gateway for the flows of corporate business from China and the wider Asian region. The BVI office will also service clients in North America and the growing markets in Latin America.
Georges-Thomas advises on all aspects
Quilvest Group, a wealth manager and private equity investor, has opened two offices in São Paulo, Brazil and Geneva, Switzerland.
The offices are Quilvest’s 12th and 13th worldwide.
Both offices will be fully integrated with Quilvest’s global network and involved in business development. The São Paulo office will focus on direct and co-investments as well as private equity and real estate fund investments, while the Geneva office will focus on wealth management.
The São Paulo office will headed by Daniel Arippol. He joined Quilvest Private Equity in 2011 and focuses on fund selection for QS GEO PEP, Quilvest Private Equity
In response to increased demand for outsourced compliance services in the marketplace, Avalon Lake Partners has recruited Harris Bogner, an attorney and compliance expert, to head its compliance services group.
Bogner’s role at Avalon Lake Partners will be to work directly with clients to ensure they develop a strong understanding of their compliance obligations while providing them with practical, cost-effective solutions.
Avalon Lake Partners recently spun-out from WTP Advisors to focus on providing a comprehensive set of advisory services to the alternative asset management industry, namely hedge funds, private equity firms and family offices.
“Finding someone of Harris’ experience
August Equity has strengthened its investment team with the appointment of Stuart Quin as an Investment Director who will focus primarily on investing across the healthcare sector.
Quin has worked in the private equity industry for seven years, most recently as the lead healthcare investor at 3i in the UK. Prior to this, he was a manager in Accenture’s Health and Life Sciences Strategy consulting practice based in Washington DC. He has a PhD in Immunology from Imperial College, London, an MBA from INSEAD in France/Singapore and a BSc from Edinburgh University.
Philip Rattle, Managing Partner, says: “We are delighted with
Ahmed Hamdani and Duncan Priston have joined the London team of Bayside Capital, the distressed debt and special situations affiliate of HIG Capital.
Hamdani has more than ten years of experience in the European distressed market. He was previously a portfolio manager at Trafalgar Asset Managers, a London based credit hedge fund where he managed its distressed credit fund. At Bayside, he will lead the firm’s non-corporate distressed investment team focusing on a number of asset classes including real estate, shipping and aircraft.
Priston has over ten years experience in the European distressed market. He was previously a partner
Newco Energy Acquisition Holdings (NEAH Energy), an energy-related asset and services acquisition firm, has appointed Kevin Stringer as chief financial officer and member of its advisory board.
Stringer currently provides guidance on a broad array of corporate finance, business strategy, and governance issues to institutional investors and private equity clients engaged in emerging and frontier markets.
Stringer is a seasoned finance professional, progressively building expertise over a career focused on providing advisory and transactional services to clients in both the public and private sectors. His experience in foreign markets includes valuation and due diligence of closely held companies for clients
Haseeb Aziz has joined the London team of HIG WhiteHorse, the credit arm of HIG Capital, specialising in providing debt capital to profitable middle market companies in Europe and the US.
Prior to joining HIG, Haseeb was a partner at Hutton Collins Partners, a subordinated debt and preferred equity fund manager, where he was responsible for originating, structuring and monitoring investments. He has completed and led a significant number of transactions over the last ten years.
Haseeb’s career has involved leveraged finance at Merrill Lynch, management consulting at Marakon, private debt placements at Deutsche Bank and mergers and acquisitions at
Alternative asset manager The Carlyle Group has named Robert Mancini a managing director and co-head of the Infrastructure Fund, joining founding co-head Robert Dove.
Mancini is currently a managing director at The Goldman Sachs Group with responsibility for power asset investments made through Cogentrix Energy, an independent power producer and wholly owned subsidiary of Goldman Sachs. Mancini is currently also the chief executive of Cogentrix.
He will join Carlyle upon the completion of the acquisition, expected in the fourth quarter of 2012, by Carlyle of Cogentrix’s North American business and will be based in New York.
Dove says: “We are
Ogier London, in its role as long term BVI legal adviser to Touchstone Gold, has assisted with Touchstone’s acquisition of Atlantis Gold Mines.
The new business combination has resulted in the creation of a Colombia focused gold exploration and development company.
Ogier London acted for Touchstone on its 2011 AIM listing and has now assisted on its migration to Canada to facilitate the acquisition of Atlantis.
The Ogier team was led by London managing partner Simon Dinning and senior associate Wendy Walker and worked with UK counsel Fladgate and Canadian counsel Cassels Brock.
Dinning says: "We have
Private equity firm Avista Capital Partners has appointed Brian A Markison as a healthcare industry executive.
Markison has more than 30 years of experience in the pharmaceuticals sector, most recently as president and chief executive officer of Fougera Pharmaceuticals, a dermatology-focused pharmaceuticals company that was spun off from Nycomed in 2011 and sold to Sandoz, the generics division of Novartis, in July 2012.
Thompson Dean, co-managing partner and chief executive officer of Avista, says: "We have known and worked with Brian for years, and we are delighted to have him join our team. The healthcare sector has been a core
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
